Rydex S&P SmallCap 600 Pure Growth Fund Class A (RYSGX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
48.51
+0.35 (0.73%)
Mar 5, 2025, 4:00 PM EST
-8.16% (1Y)
| Fund Assets | 4.91M |
| Expense Ratio | 1.55% |
| Min. Investment | $2,500 |
| Turnover | n/a |
| Dividend (ttm) | 5.60 |
| Dividend Yield | 11.30% |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 12, 2024 |
| Previous Close | 48.16 |
| YTD Return | -4.64% |
| 1-Year Return | 1.24% |
| 5-Year Return | 59.87% |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | n/a |
| Holdings | 135 |
| Inception Date | Sep 1, 2004 |
About RYSGX
The Rydex S&P SmallCap 600 Pure Growth Fund Class A (RYSGX) seeks to provide investment results that match the performance of a benchmark for small-cap growth securities. RYSGX will invest at least 80% of its assets in securities of companies in the underlying index.
Category Small Growth
Performance Rating Low
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol RYSGX
Share Class Class A
Index S&P SmallCap 600 Pure Growth TR
Performance
RYSGX had a total return of 1.24% in the past year. Since the fund's inception, the average annual return has been 6.23%, including dividends.
Top 10 Holdings
13.95% of assets| Name | Symbol | Weight |
|---|---|---|
| Cinemark Holdings, Inc. | CNK | 1.57% |
| InterDigital, Inc. | IDCC | 1.48% |
| DXP Enterprises, Inc. | DXPE | 1.47% |
| Protagonist Therapeutics, Inc. | PTGX | 1.47% |
| TG Therapeutics, Inc. | TGTX | 1.44% |
| Cal-Maine Foods, Inc. | CALM | 1.39% |
| Palomar Holdings, Inc. | PLMR | 1.34% |
| ADMA Biologics, Inc. | ADMA | 1.29% |
| The Greenbrier Companies, Inc. | GBX | 1.25% |
| The Chefs' Warehouse, Inc. | CHEF | 1.24% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 12, 2024 | $5.59573 | Dec 12, 2024 |
| Dec 9, 2021 | $29.9613 | Dec 9, 2021 |
| Dec 12, 2018 | $4.93049 | Dec 12, 2018 |
| Dec 14, 2017 | $2.50805 | Dec 14, 2017 |